The outlook for Pfizer's experimental obesity drug danuglipron is murky at best. Pfizer could pick up another obesity drug via an acquisition, but management says a near-term deal is unlikely. Still, ...

(Bloomberg) -- Pfizer Inc. got a reprieve — at least for now — in its battle with activist investor Starboard Value LP, according to people familiar with the matter. Starboard did not nominate any ...

Moderna has sued Pfizer, BioNTech in high-stakes patent case Pfizer and BioNTech said inventions were "known long before" Moderna patents Pfizer and its German partner told, opens new tab the U.S.

BridgeBio Pharma is preparing to compete against a blockbuster Pfizer product for a rare disease with few treatment options. A new financing deal provides the company with the capital to support ...

Pfizer’s recent earnings call presented a mixed sentiment, reflecting both strategic advancements and challenges. While the company highlighted significant progress in its strategic agreements and R&D ...

I have downgraded Pfizer Inc. stock to Strong Sell due to stagnant revenue, substantial patent cliffs, regulatory, legal, and reputational headwinds, and overvaluation concerns. Despite a 24.7% YoY ...

Pfizer’s shares, after a year of modest growth, recently fell following a cautious outlook for 2026, emphasizing ongoing ...

Pfizer's foundation remains solid, based on strong cash flows generated from a basket of diverse drugs. The company's large size confers significant competitive advantages in developing new drugs.

Weight loss translates to investor profits. Just look at Eli Lilly and Novo Nordisk. Both stocks have skyrocketed thanks largely to their obesity drugs, with Lilly's share price more than quadrupling ...

Aug 28 (Reuters) - Pfizer PFE.N and BioNTech 22UAy.DE asked a U.S. government tribunal on Monday to cancel patents on COVID-19 vaccine technology that rival Moderna MRNA.O has accused the companies of ...

Pfizer Inc. got a reprieve — at least for now — in its battle with activist investor Starboard Value LP, according to people familiar with the matter. Starboard did not nominate any directors to ...